Aspirin inhibits proliferation of gemcitabine-resistant human pancreatic cancer cells and augments gemcitabine-induced cytotoxicity

被引：0
|
作者：
Yan-qiu Ou
Wen-bo Zhu
Yan Li
Peng-xin Qiu
Yi-jun Huang
Jun Xie
Song-min He
Xiao-ke Zheng
Tian-dong Leng
Dong Xu
Guang-mei Yan
机构：
[1] Zhong-shan Medical College,Department of Pharmacology
[2] Sun Yat-Sen University,undefined
来源：
Acta Pharmacologica Sinica | 2010年 / 31卷
关键词：
aspirin; human pancreatic cancer; gemcitabine; apoptosis; GSK-3β; cyclin D1; Bcl-2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：73 / 80
页数：7
相关论文
共 50 条
  • [11] IFN-γ induces apoptosis in gemcitabine-resistant pancreatic cancer cells
    Kong, Xiangxin
    Cheng, Denglong
    Xu, Xu
    Zhang, Yuan
    Li, Xin
    Pan, Wanlong
    MOLECULAR MEDICINE REPORTS, 2024, 29 (05)
  • [12] Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
    Ami N. Shah
    Justin M. Summy
    Jing Zhang
    Serk In Park
    Nila U. Parikh
    Gary E. Gallick
    Annals of Surgical Oncology, 2007, 14 : 3629 - 3637
  • [13] Gemcitabine-induced myositis in a patient with pancreatic cancer
    Rubnitz, Zach
    Nevala-Plagemann, Chris
    Florou, Vaia
    Garrido-Laguna, Ignacio
    BMJ CASE REPORTS, 2025, 18 (01)
  • [14] Development and characterization of gemcitabine-resistant pancreatic tumor cells
    Shah, Ami N.
    Summy, Justin M.
    Zhang, Jing
    Park, Serk In
    Parikh, Nila U.
    Gallick, Gary E.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (12) : 3629 - 3637
  • [15] Adenoviral Therapy Is More Effective in Gemcitabine-resistant Pancreatic Cancer than in Gemcitabine-sensitive Cells
    Yasui, Takaharu
    Ohuchida, Kenoki
    Zhao, Ming
    Cui, Lin
    Onimaru, Manabu
    Egami, Takuya
    Fujita, Hayato
    Ohtsuka, Takao
    Mizumoto, Kazuhiro
    Matsumoto, Kunio
    Tanaka, Masao
    ANTICANCER RESEARCH, 2011, 31 (04) : 1279 - 1287
  • [16] Options for the Treatment of Gemcitabine-Resistant Advanced Pancreatic Cancer
    Gounaris, Ioannis
    Zaki, Kamarul
    Corrie, Pippa
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 113 - 123
  • [17] Establishment of gemcitabine-resistant human pancreatic cancer cells and effect of Brefeldin-A on the resistant cell line
    Togawa, A
    Ito, H
    Kimura, F
    Shimizu, H
    Ohtsuka, M
    Shimamura, F
    Yoshidome, H
    Katoh, A
    Miyazaki, M
    PANCREAS, 2003, 27 (03) : 220 - 224
  • [18] Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine
    Yu, Yue
    Ding, Fei
    Gao, Meng
    Jia, Yi Fu
    Ren, Le
    ONCOLOGY LETTERS, 2019, 18 (03) : 3065 - 3071
  • [19] Ribonucleotide reductase is an effective target to overcome gemcitabine resistance in gemcitabine-resistant pancreatic cancer cells with dual resistant factors
    Minami, Kentaro
    Shinsato, Yoshinari
    Yamamoto, Masatatsu
    Takahashi, Homare
    Zhang, Shaoxuan
    Nishizawa, Yukihiko
    Tabata, Sho
    Ikeda, Ryuji
    Kawahara, Kohich
    Tsujikawa, Kazutake
    Chijiiwa, Kazuo
    Yamada, Katsushi
    Akiyama, Shin-ichi
    Perez-Torras, Sandra
    Pastor-Anglada, Marcal
    Furukawa, Tatsuhiko
    Yasuo, Takeda
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (03) : 319 - 325
  • [20] Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells
    Lin, Ji-Hua
    Chen, Sheng-Yi
    Lu, Chi-Cheng
    Lin, Jer-An
    Yen, Gow-Chin
    PHYTOTHERAPY RESEARCH, 2020, 34 (08) : 2053 - 2066
12345